Pyrimethamine Elicits Antitumor Effects on Prostate Cancer by Inhibiting the p38-NF-κB Pathway

Since incurable castration-resistant prostate cancer (CRPC) inevitably develops following treatment with androgen deprivation therapy, there is an urgent need to devise new therapeutic strategies to treat this cancer. Pyrimethamine, an FDA-approved antimalarial drug, is known to exert an antitumor a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Pharmacol
Main Authors: Zhou, Xumin, Zhang, Jinming, Hu, Xiaoping, He, Peiqing, Guo, Jianyu, Li, Jun, Lan, Tian, Liu, Jumei, Peng, Lilan, Li, Hua
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2020
Assuntos:
Pharmacology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7261869/
https://ncbi.nlm.nih.gov/pubmed/32523533
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.00758
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados